MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$17,414K
Loss before
provision for income taxes
-$17,414K
Other income
(expense), net
$25,026K
Loss from operations
-$42,439K
Revenue
$7,252K
Total operating
expenses
$49,691K
Research and development
$25,582K
General and
administrative
$24,109K
Total direct program
expenses
$15,726K
Payroll and
payroll-related expenses
$7,765K
Other research and
development expenses
$2,091K
Back
Back
Income Statement
source: myfinsight.com
Ovid Therapeutics Inc. (OVID)
Ovid Therapeutics Inc. (OVID)